ResearchPod Summary
Pregnancy triggers significant cardiovascular adaptations to support maternal and fetal needs. While maternal obesity is a known risk factor for pregnancy complications, the specific influence of high body mass index (BMI ≥35 kg/m2) on maternal haemodynamic parameters throughout gestation remains under-researched and contested. This study aimed to characterize these cardiovascular adaptations by comparing women with high BMI to low-risk, healthy controls.
This prospective observational study recruited 329 pregnant women—125 in the high BMI group (≥35 kg/m2) and 189 in a low-risk control group (BMI 18.5–24.9 kg/m2). Researchers employed non-invasive cardiac output monitoring (NicOM) using bioreactance technology to assess key haemodynamic parameters: cardiac output (CO), stroke volume (SV), total peripheral resistance (TPR), and various blood pressure metrics. Measurements were collected across five distinct gestational windows, ranging from the first trimester to term (≥38 weeks), to capture longitudinal physiological changes.
Women with high BMI consistently displayed higher median CO and SV across all gestational windows compared to their lean counterparts. This elevated cardiac output was primarily driven by increased SV, as heart rate remained similar between the two groups. To compensate for this increased output, women with high BMI demonstrated significantly lower total peripheral resistance. Despite this reduction in resistance, these women maintained higher systolic blood pressure and mean arterial pressure throughout much of their pregnancy. Furthermore, the high BMI group experienced a significantly higher rate of antenatal complications, including gestational diabetes and a higher incidence of caesarean section.
The study provides critical reference data on how obesity influences maternal cardiovascular function. By highlighting that high BMI pregnancies involve a specific haemodynamic state—characterized by high flow and lower peripheral resistance—the research suggests that standard clinical monitoring may fail to capture the unique cardiovascular load placed on these patients. These findings underscore the potential need for targeted, specialized antenatal monitoring to better identify those at risk for placental-mediated diseases.
AI-generated third-party summary by ResearchPod. Not official content or an endorsement by the paper authors or affiliated organizations.